A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout.
Clinical trial NCT06298071 · RECRUITING
Trial details
- NCT number
- NCT06298071
- Sponsor
- Shanghai Institute Of Biological Products
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-03
- Primary completion
- 2026-12-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.